Company Profile

Pricing data not available
Detailed Quote
Open: $ n/a   Volume: n/a
High: $ n/a   Yield(%) n/a
Low: $ n/a   P/E Ratio (ttm): n/a
Dividend ($): n/a   Market Cap ($): n/a
EPS ($) n/a   Shares Out: n/a
M = Million B = Billion
Price Performance
% Price Change (last 4 weeks): -2.10
% Price Change (last 13 weeks): -12.90
% Price Change (last 26 weeks): -28.41
% Price Change (last 52 weeks): 2.36
% Price Change (year to date): -25.99
Management Effectiveness
Return on Equity (%): 3.09
Return on Assets (%): 1.47
Return on Invested Capital (%): 16.10
Gross Profit Margin (%): 21.77
Net Profit Margin (%): 2.79
Operating Profit Margin (%): 10.83
Price & Volume
50-day Moving Average: $219.12
200-day Moving Average: $253.21
Avg. Daily Vol. (last 50 days): 513,170
Avg. Daily Vol. (last 200 days): 531,447
52-wk high: $n/a
52-wk low: $n/a
Bid: $n/a
Ask: $n/a
Company Information
ICON plc operates as a clinical research organization, which engages in the provision of outsourced development services to the pharmaceutical, biotechnology, and medical device industries. It specializes in the strategic development, management and analysis of programs that support clinical development. The company was founded by John Climax and Ronan Lambe in June 1990 and is headquartered in Dublin, Ireland.
South County Business Park Leopardstown
Dublin DU 18

Phone: 353.1.291.2000
Fax: 353.1.247.6260
Per Share Data
Earnings (1year) ($): 2.54
Annual Dividend ($): 0.00
Current P/E Ratio (ttm): n/a
Book Value ($): 98.91
Cash Flow ($): 6.30
Valuation Ratios
Price/Earnings (x): 86.20
Price/Sales (x): 3.85
Price/Book (x): 3.13
Price/Cash Flow (x): 26.39
Financial Strength
Quick Ratio (x): 1.19
Current Ratio (x): 1.19
LT Debt/Equity (x): 68.68
Total Debt/Equity (x): 69.99

Quotes displayed with 15 minutes delay. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions. Legal Statement. News provided by MT Newswires, a Division of MidnightTrader, Inc. Events Data provided by Wall Street Horizon. ©2021 Wall Street Horizon, Inc.